Extracted from this filing and checked against the source text.
Equity Issuances
SEC 8-K Item 3.02/3.03
confidence 0.9
Aptevo Therapeutics Inc. issued common stock to YA II PN, LTD. for up to $60.0 million.
- Security
- common stock
- Purchaser
- YA II PN, LTD.
- Consideration
- up to $60.0 million
Exact text from the filing
to the Purchase Agreement, the Company has the right, but not the obligation, to issue and sell to Yorkville from time to time (each such occurrence, an “Advance”) up to $60.0 million (the “Commitment Amount”) of the Company’s common stock, $0.001 par value per share (“Common Stock”), during the 36 months following the execution of the Purchase Agreement,
View on SEC.gov
Material Agreements
SEC 8-K Item 1.01/1.02
confidence 0.9
Aptevo Therapeutics Inc. entered into Standby Equity Purchase Agreement with YA II PN, LTD. valued at up to $60.0 million (effective 2026-01-08).
- Action
- entry
- Agreement
- equity purchase
- Counterparty
- YA II PN, LTD.
- Value
- up to $60.0 million
- Effective
- 2026-01-08
Exact text from the filing
On January 8, 2026, Aptevo Therapeutics Inc. (the "Company") entered into a Standby Equity Purchase Agreement (the "Purchase Agreement") with YA II PN, LTD., a Cayman Islands exempt limited company ("Yorkville"). Pursuant to the Purchase Agreement, the Company has the right, but not the obligation, to issue and sell to Yorkville from time to time (each such occurrence, an "Advance") up to $60.0 million (the "Commitment Amount") of the Company's common stock
View on SEC.gov